Member Info for Timster

Hurstbot does not have the AI conversational upgrade and just posts utter ******

Great news, you wait till the internet is turned on in the US at 2.30 mrR things are going to get tasty
COLDA conference starts in 2 weeks hustbot surprised you've not mentioned it...

Wouldn't want to be out, BEGO on the bid USD up, volume buyer etc etc

Wow this thread has gone awry

I'd add to the dosier of evidence the job adverts where it clearly says it works

For balance, that is a very old interview probably even before the trial began

Anyone who has experienced or known someone who has experienced chemo will know how awful the side effects are. A treatment that minimises them while maximizing the tumours exposure to the chemo drug is an incredible step forward.

If the platform is proven, that's what we are looking at.

Think about that for a minute....

Absolutely earth shattering in the standard of care for cancer sufferers.....

Oh, the irony....

We can be fairly sure news will come of the trial in the next 3 months.

The last cohort was only 2 months so guessing they wouldn't need to go any longer with cohort 4.

Difference is wynbore you would have created a thread with a 10000 word essay claiming to be a world renowned expert.

I just created a stupid thread not to be taken seriously

Oooo I like a good guessing game

T for twat?

"they" know something, "they" are watching, "they " have been to ESMO

Positive phase 1a data prove the pre|CISION platform and the pipeline opens up.

Will be a massive day for avactarians

Looks like the insiders know something

RNS tomorrow, AS loves a Thursday RNS

Could be talking about the bit of joint research they did back in the day though
https://polaris.brighterir.com/public/avacta/news/rns/story/w6ezzgr

That bits made up but the rest is spot on

"We have Japan's largest pharma company, Takeda, in active negotiations with @avacta."
Really??

Has ESMO finished Hurstbot?

It's been as transformational on avacta SP as ASCO was.... Well done all

From what I understand reading the board we are waiting for results from a phase 1 clinical trial on the lft it'll be ready soon.
I think that's correct